SCHEMBL6973877

SCHEMBL6973877

N=CN.c1ccc(Cc2cn(Cc3ccncc3)cn2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.45
CYP2D6 P10635 3/20 0.45
CYP2C9 P11712 2/20 0.45
CYP2C19 P33261 2/20 0.45
CYP2E1 P05181 1/20 0.45
CYP2A6 P11509 1/20 0.45
CYP2B6 P20813 1/20 0.45
CYP11B1 P15538 4/20 0.42
CYP11B2 P19099 3/20 0.42
CYP1A2 P05177 2/20 0.42
CYP19A1 P11511 2/20 0.42
POLB P06746 1/20 0.42
MAPT P10636 1/20 0.42
TBXAS1 P24557 1/20 0.42
QPCT Q16769 1/20 0.42
CYP4Z1 Q86W10 1/20 0.42
QPCTL Q9NXS2 1/20 0.42
HPGDS O60760 1/20 0.40
KDM5A P29375 1/20 0.40
KDM4C Q9H3R0 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6955809 0.88 HPGDS (0.39) CYP3A4CYP2D6CYP2C9CYP2C19CYP2E1
SCHEMBL30741761 0.85 HPGDS (0.50) CYP3A4CYP2D6CYP2C9CYP2C19CYP2E1
SCHEMBL6972535 0.85 KDM4C (0.38) CYP3A4CYP2D6CYP2C9CYP2C19CYP2E1
SCHEMBL6974237 0.84 CDK5 (0.51) CYP3A4CYP2D6CYP2C9CYP2C19CYP11B1
SCHEMBL6952807 0.79 SIGMAR1 (0.45) CYP3A4CYP2D6CYP2C9CYP2C19CYP2E1
SCHEMBL6968013 0.74 KDM4C (0.40) CYP11B1CYP11B2HPGDSKDM5AKDM4C
SCHEMBL6965586 0.74 THRB (0.39) CYP2A6CYP2B6CYP11B1CYP11B2CYP19A1
SCHEMBL6972346 0.74 PHF8 (0.38) CYP3A4CYP2D6CYP2C9CYP2C19CYP2E1
SCHEMBL28417084 0.73 HPGDS (0.50) CYP3A4CYP2D6CYP2C9CYP2C19CYP2E1
SCHEMBL6182324 0.72 LTA4H (0.40) CYP2C9CYP2C19LTA4HCPB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729459-B1 PHENYL-ALKYL IMIDAZOLES AS H3-RECEPTOR ANTAGONISTS SCHERING CORP (US) 2003-03-12 EP disclosed
US-5578616-A ANTIINFLAMMATORY AGENTS, ANTIALLERGENS, TREATMENT FOR GASTROINTESTINAL AND CARDIOVASCULAR DISORDERS SCHERING CORPORATION (US) 1996-11-26 US disclosed